Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
129.2 USD | -0.70% | +1.69% | +18.35% |
11:00am | BioMed X Announces the Start of A New Research Project in Partnership with Merck | CI |
Apr. 29 | Merck Reports Positive Data for Investigational 21-Valent Pneumococcal Vaccine | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.35% | 330B | |
+33.44% | 664B | |
+29.29% | 567B | |
-7.61% | 354B | |
+4.57% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.68% | 148B | |
-10.99% | 145B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Transcript : Merck & Co., Inc. Presents at Ginkgo's Annual Ferment Conference 2024, Apr-11-2024 09